Volume 22 - Issue 11 - November, 2014
11/05/2014
Cath Lab Digest talks with Daniel P. O’Hair, MD, Director, Cardiovascular and Thoracic Surgeon at Aurora St. Luke’s Medical Center, Milwaukee, Wisconsin.
Cath Lab Digest talks with Daniel P. ...
TAVR is labor intensive and we aim to make the best use of our resources. Over the next few weeks, we will have visitors from around the country and as far away as France coming to study our efficiency.
TAVR is labor intensive and we aim to make the best use of our resources. Over the next few weeks, we will have visitors from around the country and as far away as France coming to study our efficiency.
TAVR is labor intensive and we...
11/05/2014
Cath Lab Digest
11/05/2014
Daniel P. O’Hair, MD, Director, Cardiovascular and Thoracic Surgeon at Aurora St. Luke’s Medical Center, Milwaukee, Wisconsin
Daniel P. O’Hair, MD, Director, Cardi...
The key to our new hybrid OR is the Discovery IGS 730 (GE Healthcare), which aids our physicians in performing complex procedures like endovascular aortic repairs (EVAR), transcatheter aortic valve replacements (TAVR), and atrial fibrillation...
The key to our new hybrid OR is the Discovery IGS 730 (GE Healthcare), which aids our physicians in performing complex procedures like endovascular aortic repairs (EVAR), transcatheter aortic valve replacements (TAVR), and atrial fibrillation...
The key to our new hybrid OR is...
11/05/2014
Cath Lab Digest
Column
Technology Pulse
11/05/2014
J.A. Mustapha, MD, Larry J. Diaz-Sandoval, MD, Fadi Saab, MD, Metro Health Hospital, Wyoming, Michigan
J.A. Mustapha, MD, Larry J. Diaz-Sand...
The DCB represents a technology that is able to carry and deliver an anti-proliferative drug to the arterial wall at the same time the mechanical treatment is provided to the obstructive atherosclerotic plaque. Understanding this apparently...
The DCB represents a technology that is able to carry and deliver an anti-proliferative drug to the arterial wall at the same time the mechanical treatment is provided to the obstructive atherosclerotic plaque. Understanding this apparently...
The DCB represents a technology...
11/05/2014
Cath Lab Digest
Clinical Editor's Corner
11/05/2014
Given what we now understand about closure devices and femoral angiography, I found it strange that this question would come up, but I put it out to my colleagues on the “Cath List” to see what the conversation might be.
Given what we now understand about closure devices and femoral angiography, I found it strange that this question would come up, but I put it out to my colleagues on the “Cath List” to see what the conversation might be.
Given what we now understand...
11/05/2014
Cath Lab Digest
